|
TOP1P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.330200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.393960E-01 |
| Normal-vs-Stage2 |
9.050000E-01 |
| Normal-vs-Stage3 |
7.061000E-01 |
| Normal-vs-Stage4 |
4.878800E-01 |
| Stage1-vs-Stage2 |
3.402400E-01 |
| Stage1-vs-Stage3 |
7.944000E-01 |
| Stage1-vs-Stage4 |
2.919000E-01 |
| Stage2-vs-Stage3 |
7.128400E-01 |
| Stage2-vs-Stage4 |
5.130000E-01 |
| Stage3-vs-Stage4 |
3.955600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.098400E-01 |
| Normal-vs-AfricanAmerican |
8.278200E-01 |
| Normal-vs-Asian |
7.026400E-01 |
| Caucasian-vs-AfricanAmerican |
6.842000E-01 |
| Caucasian-vs-Asian |
7.578400E-01 |
| AfricanAmerican-vs-Asian |
6.425200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.402000E-01 |
| Normal-vs-Female |
9.040000E-01 |
| Male-vs-Female |
6.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.184000E-01 |
| Normal-vs-Extreme_Weight |
8.257800E-02 |
| Normal-vs-Obese |
3.129400E-01 |
| Normal-vs-Extreme_Obese |
2.207800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.981600E-01 |
| Normal_Weight-vs-Obese |
2.563800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.462400E-01 |
| Extreme_Weight-vs-Obese |
1.414180E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.832600E-01 |
| Obese-vs-Extreme_Obese |
1.111550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.830000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.215400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.956000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.982000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.357400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.247200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.104380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.490500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.056230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.032000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.911400E-01 |
| Normal-VS-Type2 PRCC |
2.279400E-01 |
| Normal-VS-KIRP CIMP |
8.570600E-04 |
| Normal-VS-Unclassified PRCC |
8.375000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.289700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.956700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.762800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.598200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.155800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.555200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.273400E-01 |
| Normal-vs-N1 |
2.746000E-01 |
| Normal-vs-N2 |
5.405600E-01 |
| N0-vs-N1 |
1.811170E-01 |
| N0-vs-N2 |
9.145600E-01 |
| N1-vs-N2 |
5.040600E-01 |
|
|
